Citrullination of Inhibitor of Growth 4 (ING4) by Peptidylarginine Deminase 4 (PAD4) Disrupts the Interaction between ING4 and p53

被引:94
作者
Guo, Qin [1 ]
Fast, Walter [1 ]
机构
[1] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA
基金
美国国家卫生研究院;
关键词
TUMOR-SUPPRESSOR ING4; MYELIN BASIC-PROTEIN; ARGININE DEIMINASE 4; STRUCTURAL BASIS; GENE-EXPRESSION; METHYLATION; BINDING; DEMETHYLIMINATION; ACTIVATION; DEACETYLATION;
D O I
10.1074/jbc.M111.230961
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene expression is regulated by a number of interrelated posttranslational modifications of histones, including citrullination. For example, peptidylarginine deminase 4 (PAD4) converts peptidyl arginine to citrulline in histone H3 and can repress gene expression. However, regulation of gene expression through citrullination of non-histone proteins is less well defined. Herein, we identify a tumor suppressor protein, inhibitor of growth 4 (ING4), as a novel non-histone substrate of PAD4. ING4 is known to bind p53 via its nuclear localization signal (NLS) region and to enhance transcriptional activity of p53. We show that PAD4 preferentially citrullinates ING4 in the same NLS region and thereby disrupts the interaction between ING4 and p53. A citrulline-mimicking Arg-NLS-Gln ING4 mutant, which has all Arg residues in the NLS mutated to Gln, loses its affinity for p53, can no longer promote p53 acetylation, and results in repression of downstream p21 expression. In addition, we found that citrullination leads to increased susceptibility of ING4 to degradation, likely impacting p53-independent pathways as well. These findings elucidate an interaction between posttranslational citrullination, acetylation, and methylation and highlight an unusual mechanism whereby citrullination of a non-histone protein impacts gene regulation.
引用
收藏
页码:17069 / 17078
页数:10
相关论文
共 38 条
[1]   Autocitrullination of Human Peptidyl Arginine Deiminase Type 4 Regulates Protein Citrullination During Cell Activation [J].
Andrade, Felipe ;
Darrah, Erika ;
Gucek, Marjan ;
Cole, Robert N. ;
Rosen, Antony ;
Zhu, Xiaoming .
ARTHRITIS AND RHEUMATISM, 2010, 62 (06) :1630-1640
[2]   Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4 [J].
Arita, K ;
Shimizu, T ;
Hashimoto, H ;
Hidaka, Y ;
Yamada, M ;
Sato, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5291-5296
[3]   Structural basis for Ca2+-induced activation of human PAD4 [J].
Arita, K ;
Hashimoto, H ;
Shimizu, T ;
Nakashima, K ;
Yamada, M ;
Sato, M .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (08) :777-783
[4]   An Arg/Lys→Gln mutant of recombinant murine myelin basic protein as a mimic of the deiminated form implicated in multiple sclerosis [J].
Bates, IR ;
Libich, DS ;
Wood, DD ;
Moscarello, MA ;
Harauz, G .
PROTEIN EXPRESSION AND PURIFICATION, 2002, 25 (02) :330-341
[5]   Crystallization and preliminary X-ray diffraction analysis of the dimerization domain of the tumour suppressor ING4 [J].
Culurgioni, Simone ;
Munoz, Ines G. ;
Palacios, Alicia ;
Redondo, Pilar ;
Blanco, Francisco J. ;
Montoya, Guillermo .
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2010, 66 :567-570
[6]   Histone deimination antagonizes arginine methylation [J].
Cuthbert, GL ;
Daujat, S ;
Snowden, AW ;
Erdjument-Bromage, H ;
Hagiwara, T ;
Yamada, M ;
Schneider, R ;
Gregory, PD ;
Tempst, P ;
Bannister, AJ ;
Kouzarides, T .
CELL, 2004, 118 (05) :545-553
[7]   Functional Connection between Deimination and Deacetylation of Histones [J].
Denis, Helene ;
Deplus, Rachel ;
Putmans, Pascale ;
Yamada, Michiyuki ;
Metivier, Raphael ;
Fuks, Francois .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (18) :4982-4993
[8]   Decreased Expression of Inhibitor of Growth 4 Correlated with Poor Prognosis of Hepatocellular Carcinoma [J].
Fang, Feng ;
Luo, Lai-Bang ;
Tao, Yi-Ming ;
Wu, Fan ;
Yang, Lian-Yue .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) :409-416
[9]   Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain [J].
Gu, W ;
Roeder, RG .
CELL, 1997, 90 (04) :595-606
[10]  
Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616